NCT00071799 A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care Status COMPLETED Phase PHASE3
NCT00006019 Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer Status COMPLETED Phase PHASE2
NCT00005598 Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00004871 Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT00004062 Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer Status COMPLETED Phase PHASE1